TSH alone is not sufficient to exclude all patients with a functioning thyroid nodule from undergoing testing to exclude thyroid cancer
- 154 Downloads
The purpose of the study was to analyze whether the thyroid-stimulating hormone (TSH) alone avoids tests to exclude malignancy in all patients with functional thyroid nodules (FTN).
Sixty-nine patients with FTN on 99mTc scintigraphy, radioiodine uptake test (RIU), 99mTc thyroid uptake, TSH assay, T3, and T4 obtained within 48 h were retrospectively identified out of 2,356 thyroid scans performed from January 2000 to April 2007. FTNs were classified as causing total, partial, or no inhibition of the thyroid as group 1, 2, or 3, respectively.
TSH was subnormal in 21 of 69 (30.43%) patients. In group 1 (N = 23, 33.3%), TSH was subnormal, normal, and high in eight, nine, and six patients; in group 2 (N = 17, 24.6%), TSH was subnormal, normal, and high in four, six, and seven patients, and in group 3 (N = 29, 42%), TSH was subnormal, normal, and high in 9, 13, and 7 patients, respectively. TSH was significantly lower in group 1. In T3, T4, 99mTc thyroid uptake, and RIU, there were no differences between the three groups.
Only 30.43% of patients had subnormal TSH. TSH alone cannot avoid tests to exclude malignancy in all patients with FTN. FTN existence can only be accurately assessed by thyroid scintigraphy. The current incidence of FTN may be unknown because scintigraphy is not routinely performed in all patients with thyroid nodules. Thyroid scintigraphy of patients with high TSH can detect diseases such as Hashimoto’s thyroiditis and identify patients with FTN in whom no further diagnostic procedures would be needed in patients with normal TSH levels with nondiagnostic fine-needle aspiration results.
KeywordsThyroid gland Thyroid nodule Thyrotropin Radionuclide imaging 99mTc-Pertechnetate
We are grateful to Febe-Griselda Mayén-Pérez, our Senior Nuclear Medicine Technician, for her unconditional daily assistance and help in the attention of all our thyroid patients.
- 4.Ross DS. Evaluation of the Thyroid Nodule. J NucI Med 1991;32:2181–92.Google Scholar
- 7.American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi. Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules, AACE/AME Task Force on Thyroid Nodules. Endocrine Practice 2006;12:63–102.Google Scholar
- 9.Garber JR. Thyroid nodules: managing what has been known for over 50 years. Hormones (Athens) 2006;5:179–86.Google Scholar
- 16.Hurtado-López LM, Arellano-Montaño S, Torres-Acosta EM, et al. Combined use of fine needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging 2004;31:1273–9.PubMedCrossRefGoogle Scholar
- 19.Lennard TW, Proud G. Thyroid aspiration cytology in Newcastle: a six year cytology/histology correlation study. Hot nodules have a very low incidence of malignancy. Ann R Coll Surg Eng 2000;82:149–55.Google Scholar
- 22.Ravetto C, Colombo L, Dottorini ME. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: A retrospective study in 37,895 patients. Cancer Cytopathol 2000;90:357–63.Google Scholar
- 24.Lansfird CD, Teknos TN. Evaluation of the thyroid nodule. Cancer Control 2006;13:89–98.Google Scholar
- 26.Asociación Mexicana De Cirugía General. Nódulo tiroideo, 2001. Consenso. Cir Gen 2002;24:76–83.Google Scholar